Emre Yucel
About Emre Yucel
Emre Yucel is the Director of WWHEOR at Bristol Myers Squibb, with extensive experience in health economics, cancer research, and pharmacy consultancy.
Current Role at Bristol Myers Squibb
Emre Yucel is currently serving as a Director of Worldwide Health Economics and Outcomes Research (WWHEOR) at Bristol Myers Squibb. Based in Princeton, NJ, he contributes to the company's strategic initiatives by analyzing and interpreting health economics and outcomes data to support product value propositions and inform healthcare decision making.
Professional Background in Health Economics
Before joining Bristol Myers Squibb, Emre Yucel worked at Amgen where he held the position of Manager, Global Health Economics for three years from 2017 to 2020. At Amgen, he was responsible for conducting health economic analyses to support product development and market access strategies. His previous experience includes a role at MD Anderson Cancer Center as a researcher in the Cancer Symptom Research Department, focusing on patient-reported outcomes and cancer symptom management from 2012 to 2016.
Pharmaceutical Consulting Experience
Emre Yucel has extensive consulting experience in the pharmaceutical industry. He served as a Pharmacist Consultant at Güven Eczanesi and Rekra and Yucel Pharmacy for several years. These roles involved providing expert guidance on pharmaceutical practices and quality assurance. His early career includes positions at Bilim Pharmaceuticals as a Quality Assurance Supervisor and at Deva as a Business Development Manager, where he managed pharmaceutical projects and quality assurance processes.
Educational Background and Expertise
Emre Yucel holds a Doctor of Philosophy (Ph.D.) in Epidemiology with a minor in Biostatistics from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health. Additionally, he earned a Master of Pharmacoepidemiology and Pharmacoeconomics from Yeditepe University, a Master of Clinical Pharmacy from Marmara University, and a Master of Business Administration (M.B.A.) in International Business from the University of South Carolina. His educational background encompasses public health, pharmacy, and business administration, equipping him with a broad expertise in health economics and research.
Publications and Research Contributions
Emre Yucel has co-authored several notable publications in the field of health economics and outcomes research. His work includes studies such as 'The symptom burden of treatment-naïve patients with head and neck cancer', 'Measuring symptoms as a critical component of drug development and evaluation in hematological diseases', and 'Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-induced Neuropathy Assessment Scale (TNAS)'. He has also conducted gap analyses of patient-reported outcomes for various types of cancer, including lung cancer, gastro-intestinal stromal tumors, and thyroid cancer.